Practice
Guidelines
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4356 (Published 17 July 2014) Cite this as: BMJ 2014;349:g4356
Related articles
- ResearchPredicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2Published: 26 June 2008; BMJ 336 doi:10.1136/bmj.39609.449676.25
- News Published: 18 July 2014; BMJ 349 doi:10.1136/bmj.g4694
- Editor's Choice Published: 24 July 2014; BMJ 349 doi:10.1136/bmj.g4793
- Letter Published: 03 September 2014; BMJ 349 doi:10.1136/bmj.g5081
- Endgames Published: 13 June 2016; BMJ 353 doi:10.1136/bmj.i3022
- Practice Published: 23 March 2018; BMJ 360 doi:10.1136/bmj.k946
- Practice Published: 23 March 2018; BMJ 360 doi:10.1136/bmj.k835
- Editorial Published: 05 September 2018; BMJ 362 doi:10.1136/bmj.k3695
- Practice Published: 23 June 2021; BMJ 373 doi:10.1136/bmj.n1486
Clinical reviewNon-cardiovascular effects associated with statins
See more
- Adrenal insufficiency: identification and management—summary of new NICE guidanceBMJ May 01, 2025, 389 r330; DOI: https://doi.org/10.1136/bmj.r330
- Identification, assessment, and management of gambling-related harms: summary of NICE guidelineBMJ March 11, 2025, 388 r323; DOI: https://doi.org/10.1136/bmj.r323
- Diagnosis and management of endometriosis: summary of updated NICE guidanceBMJ January 31, 2025, 388 q2782; DOI: https://doi.org/10.1136/bmj.q2782
- Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management—summary of updated NICE guidanceBMJ November 27, 2024, 387 q2452; DOI: https://doi.org/10.1136/bmj.q2452
- Recognition, diagnosis, and early management of suspected sepsis: summary of updated NICE guidanceBMJ June 18, 2024, 385 q1173; DOI: https://doi.org/10.1136/bmj.q1173
Cited by...
- Cardiovascular risk prediction using metabolomic biomarkers and polygenic risk scores: A cohort study and modelling analyses
- Hypertriglyceridaemia: an update
- Comparative efficacy and safety of statins for osteoporosis: a study protocol for a systematic review and network meta-analysis
- Long-term cardiovascular risk prediction in the emergency department: a mixed-methods study protocol
- Investigating raised creatine kinase
- Uptake of Statin Guidelines to Prevent and Treat Cardiovascular Disease
- Cardiovascular prevention: Frontiers in lipid guidelines
- Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis
- Primary prevention with statins for older adults
- Dyslipidaemia and cardiovascular risk
- Managing dyslipidaemia for the primary prevention of cardiovascular disease
- Correlates and assessment of excess cardiovascular risk in bronchiectasis
- Drugs for hypercholesterolaemia - from statins to pro-protein convertase subtilisin kexin 9 (PCSK9) inhibition
- Assessment of cardiovascular risk in primary care
- Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes
- Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study
- Fasting or Nonfasting Lipid Measurements: It Depends on the Question
- Alternative Strategies to Achieve Cardiovascular Mortality Goals in China and India: A Microsimulation of Target- Versus Risk-Based Blood Pressure Treatment
- Reply to Letters Regarding Article, "Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III)"
- Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins
- NICE must do better at summarising and communicating evidence on statins